Nanoparticles and brain tumor treatment (Record no. 75946)

MARC details
000 -LEADER
fixed length control field 05562nam a2200889 a 4500
001 - CONTROL NUMBER
control field vtls000079397
003 - CONTROL NUMBER IDENTIFIER
control field MTX
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m eo d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cn |||m|||a
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 160715s2012 nyua foab 000 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781606504086 (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781606504222 (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9780791860038 (print)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 0791860035 (print)
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)811139143
035 ## - SYSTEM CONTROL NUMBER
System control number (CaPaEBR)10605115
035 ## - SYSTEM CONTROL NUMBER
System control number (CaBNvSL)swl00401402
037 ## - SOURCE OF ACQUISITION
Stock number 860038
Source of stock number/acquisition ASME
039 #9 - LEVEL OF BIBLIOGRAPHIC CONTROL AND CODING DETAIL [OBSOLETE]
Level of rules in bibliographic description 201607151144
Level of effort used to assign nonsubject heading access points staff
-- 201605041227
-- admin
040 ## - CATALOGING SOURCE
Original cataloging agency CaBNVSL
Transcribing agency CaBNVSL
Modifying agency CaBNVSL
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number R857.N34
Item number N253 2012
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QT 36.5
Item number N253 2012
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 610.284
Edition number 23
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
Classification number Ebook
245 00 - TITLE STATEMENT
Title Nanoparticles and brain tumor treatment
Medium [electronic resource] /
Statement of responsibility, etc. Gerardo Caruso ... [et al.].
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. New York, N.Y. :
Name of publisher, distributor, etc. ASME ;
Place of publication, distribution, etc. [New York, N.Y.] (222 East 46th Street, New York, NY 10017) :
Name of publisher, distributor, etc. Momentum Press,
Date of publication, distribution, etc. 2012.
300 ## - PHYSICAL DESCRIPTION
Extent 1 electronic text (viii, 99 p.) :
Other physical details ill., digital file.
490 1# - SERIES STATEMENT
Series statement Biomedical and nanomedical technologies
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references (p. [81]-99).
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note 1. Introduction --
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 2. Glioma biology -- 2.1 Invasion and angiogenesis --
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 3. Blood-brain barrier -- 3.1 Blood-brain barrier physiology -- 3.2 Blood-brain barrier transport systems --
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 4. Nanomedicine and nanotechnology -- 4.1 Nanoparticle drug delivery -- 4.1.1 Nanoparticle distribution -- 4.1.2 Nanoparticle functionalization -- 4.1.3 Nanoparticle targeting -- 4.2 Nanomedicine and cancer -- 4.3 Nanomedicine and toxicity --
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 5. Nanoparticle technologies -- 5.1 Polymeric and polymer-drug conjugate nanoparticles -- 5.2 Micelle nanoparticles -- 5.3 Liposomes -- 5.4 Gold and silver nanoparticles -- 5.5 Metal oxide -- 5.6 Magnetic nanoparticles -- 5.7 Carbon nanotubes -- 5.8 Fullerenes -- 5.9 Peptides nanoparticles -- 5.10 Silica nanoparticles -- 5.11 Quantum dots -- 5.12 Dendrimers --
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 6. Nanomedicine applications in brain tumors -- 6.1 Brain tumor drug targeting -- 6.1.1 Systemic approaches -- 6.1.2 Physiological approaches -- 6.1.2.1 Receptor-mediated transcytosis -- 6.1.2.2 Adsorptive-mediated transcytosis -- 6.1.2.3 Efflux pump inhibition -- 6.1.2.4 Cell-mediated drug transport -- 6.1.3 Direct CNS approaches -- 6.1.3.1 Intracerebral routes -- 6.1.4 Drug modifications and prodrugs --
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 7. Experimental studies --
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 8. Conclusions -- References.
506 ## - RESTRICTIONS ON ACCESS NOTE
Terms governing access Restricted to libraries which purchase an unrestricted PDF download via an IP.
520 3# - SUMMARY, ETC.
Summary, etc. Despite progresses in surgery, radiotherapy, and in chemotherapy, an effective curative treatment of gliomas does not yet exist. Mortality is still close to 100% and the average survival of patients with GBM is less than 1 year. The efficacy of current anti-cancer strategies in brain tumors is limited by the lack of specific therapies against malignant cells. Besides, the delivery of the drugs to brain tumors is limited by the presence of the blood brain barrier. The oncogenesis of gliomas is characterized by several biological processes and genetic alterations, involved in the neoplastic transformation. The modulation of gene expression to more levels, such as DNA, mRNA, proteins and transduction signal pathways, may be the most effective modality to down-regulate or silence some specific gene functions. Gliomas are characterized by extensive microvascular proliferation and a higher degree of vasculature. In malignant gliomas targeted therapies efficacy is low. In this complex field, it seems to be very important to improve specific selective drugs delivery systems. Drugs, antisense oligonucleotides, small interference RNAs, engineered monoclonal antibodies and other therapeutic molecules may diffuse into CNS overcoming the BBB. Nanotechnology could be used both to improve the treatment efficacy and to reduce the adverse side effects.
530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE
Additional physical form available note Also available in print.
538 ## - SYSTEM DETAILS NOTE
System details note Mode of access: World Wide Web.
538 ## - SYSTEM DETAILS NOTE
System details note System requirements: Adobe Acrobat reader.
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Title from PDF t.p. (viewed on September 26, 2012).
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nanomedicine.
9 (RLIN) 115923
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nanoparticles.
9 (RLIN) 115924
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Brain
General subdivision Tumors
-- Treatment.
9 (RLIN) 115925
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nanomedicine.
9 (RLIN) 115923
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nanoparticles.
9 (RLIN) 115924
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Brain Neoplasms
General subdivision therapy.
9 (RLIN) 115926
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Nanomedicine
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Nanotechnology
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Nanoparticles
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Nanoparticles in Brain Tumor Treatment
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Nanoparticle Drug Delivery
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Nanoparticle Targeting
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Blood-Brain Barrier
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Glioma
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Astrocytoma
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Glioblastoma
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Brain Tumor
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Glioma Treatment
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Brain Tumor Drug Targeting
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Angiogenesis
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Polymeric
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Nanoparticles and Brain Tumors
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Carbon Nanotubes and Brain Tumors
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Fullerenes and Brain Tumors
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Silica Nanoparticles and Brain Tumors
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Micelle Nanoparticles and Brain Tumors
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Liposome and Brain Tumors
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Caruso, Gerardo.
9 (RLIN) 115927
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
International Standard Book Number 0791860035
-- 9780791860038
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Biomedical and nanomedical technologies.
9 (RLIN) 115928
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://portal.igpublish.com/iglibrary/search/MPB0000052.html">http://portal.igpublish.com/iglibrary/search/MPB0000052.html</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type eBook

No items available.



Office of Academic Resources and Information Technology
      38 Moo. 8, Nawung Sub-District, Muang Phetchaburi District, Phetchaburi 76000 Thailand
    Tel: (032) 708609  Email: library_office@mail.pbru.ac.th